These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

198 related articles for article (PubMed ID: 24024505)

  • 1. Evaluation of the cytotoxic effect of camptothecin solid lipid nanoparticles on MCF7 cells.
    Acevedo-Morantes CY; Acevedo-Morantes MT; Suleiman-Rosado D; Ramírez-Vick JE
    Drug Deliv; 2013 Nov; 20(8):338-48. PubMed ID: 24024505
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Development and evaluation of lipid nanoparticles for camptothecin delivery: a comparison of solid lipid nanoparticles, nanostructured lipid carriers, and lipid emulsion.
    Huang ZR; Hua SC; Yang YL; Fang JY
    Acta Pharmacol Sin; 2008 Sep; 29(9):1094-102. PubMed ID: 18718178
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Brain targeting effect of camptothecin-loaded solid lipid nanoparticles in rat after intravenous administration.
    Martins SM; Sarmento B; Nunes C; Lúcio M; Reis S; Ferreira DC
    Eur J Pharm Biopharm; 2013 Nov; 85(3 Pt A):488-502. PubMed ID: 23994244
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Redox sensitive lipid-camptothecin conjugate encapsulated solid lipid nanoparticles for oral delivery.
    Du Y; Ling L; Ismail M; He W; Xia Q; Zhou W; Yao C; Li X
    Int J Pharm; 2018 Oct; 549(1-2):352-362. PubMed ID: 30099214
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Camptothecin in sterically stabilized phospholipid micelles: a novel nanomedicine.
    Koo OM; Rubinstein I; Onyuksel H
    Nanomedicine; 2005 Mar; 1(1):77-84. PubMed ID: 17292061
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Camptothecin analogues with enhanced antitumor activity at acidic pH.
    Adams DJ; Dewhirst MW; Flowers JL; Gamcsik MP; Colvin OM; Manikumar G; Wani MC; Wall ME
    Cancer Chemother Pharmacol; 2000; 46(4):263-71. PubMed ID: 11052623
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Brain delivery of camptothecin by means of solid lipid nanoparticles: formulation design, in vitro and in vivo studies.
    Martins S; Tho I; Reimold I; Fricker G; Souto E; Ferreira D; Brandl M
    Int J Pharm; 2012 Dec; 439(1-2):49-62. PubMed ID: 23046667
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Sensitivity to camptothecin of human breast carcinoma and normal endothelial cells.
    Jones CB; Clements MK; Wasi S; Daoud SS
    Cancer Chemother Pharmacol; 1997; 40(6):475-83. PubMed ID: 9332461
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Biologically active camptothecin derivatives for incorporation into liposome bilayers and lipid emulsions.
    Lundberg BB
    Anticancer Drug Des; 1998 Jul; 13(5):453-61. PubMed ID: 9702210
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Enhancing the anticancer efficacy of camptothecin using biotinylated poly(ethylene glycol) conjugates in sensitive and multidrug-resistant human ovarian carcinoma cells.
    Minko T; Paranjpe PV; Qiu B; Lalloo A; Won R; Stein S; Sinko PJ
    Cancer Chemother Pharmacol; 2002 Aug; 50(2):143-50. PubMed ID: 12172980
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Nanocarrier improves the bioavailability, stability and antitumor activity of camptothecin.
    Tang XJ; Han M; Yang B; Shen YQ; He ZG; Xu DH; Gao JQ
    Int J Pharm; 2014 Dec; 477(1-2):536-45. PubMed ID: 25445532
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hydrophobically modified glycol chitosan nanoparticles-encapsulated camptothecin enhance the drug stability and tumor targeting in cancer therapy.
    Min KH; Park K; Kim YS; Bae SM; Lee S; Jo HG; Park RW; Kim IS; Jeong SY; Kim K; Kwon IC
    J Control Release; 2008 May; 127(3):208-18. PubMed ID: 18336946
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Paclitaxel-induced apoptosis is blocked by camptothecin in human breast and pancreatic cancer cells.
    Jeansonne DP; Koh GY; Zhang F; Kirk-Ballard H; Wolff L; Liu D; Eilertsen K; Liu Z
    Oncol Rep; 2011 May; 25(5):1473-80. PubMed ID: 21331447
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Liposomal formulations of poorly soluble camptothecin: drug retention and biodistribution.
    Flaten GE; Chang TT; Phillips WT; Brandl M; Bao A; Goins B
    J Liposome Res; 2013 Mar; 23(1):70-81. PubMed ID: 23210622
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Preparation, formula optimization and antitumor actions of mannitol coupling camptothecin nanoparticles.
    Wang Z; Li Q; Zhao X; Sun B; Zhu Q; Gao W; Hua C
    Int J Pharm; 2014 Apr; 465(1-2):360-7. PubMed ID: 24530520
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Solid lipid nanoparticles of anticancer drugs against MCF-7 cell line and a murine breast cancer model.
    Zhuang YG; Xu B; Huang F; Wu JJ; Chen S
    Pharmazie; 2012 Nov; 67(11):925-9. PubMed ID: 23210242
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Nanosponge-encapsulated camptothecin exerts anti-tumor activity in human prostate cancer cells.
    Minelli R; Cavalli R; Ellis L; Pettazzoni P; Trotta F; Ciamporcero E; Barrera G; Fantozzi R; Dianzani C; Pili R
    Eur J Pharm Sci; 2012 Nov; 47(4):686-94. PubMed ID: 22917641
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Chitosan stabilized camptothecin nanoemulsions: Development, evaluation and biodistribution in preclinical breast cancer animal mode.
    Natesan S; Sugumaran A; Ponnusamy C; Thiagarajan V; Palanichamy R; Kandasamy R
    Int J Biol Macromol; 2017 Nov; 104(Pt B):1846-1852. PubMed ID: 28545970
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Investigation of parameters influencing incorporation, retention and cellular cytotoxicity in liposomal formulations of poorly soluble camptothecin.
    Whitaker RD; Ingebrigtsen SG; Naderkhani E; Skar ML; Flaten GE
    J Liposome Res; 2013 Dec; 23(4):298-310. PubMed ID: 23763495
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Identification of mutations at DNA topoisomerase I responsible for camptothecin resistance.
    Wang LF; Ting CY; Lo CK; Su JS; Mickley LA; Fojo AT; Whang-Peng J; Hwang J
    Cancer Res; 1997 Apr; 57(8):1516-22. PubMed ID: 9108454
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.